Current challenges and emerging opportunities of CAR-T cell therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current challenges and emerging opportunities of CAR-T cell therapies

Published:2020-03 Issue: Volume:319 Page:246-261
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Abreu Teresa R.,Fonseca Nuno A.,Gonçalves Nélio,Moreira João Nuno

Funder

CRS

European Regional Development Fund

COMPETE 2020 - Operational Programme for Competitiveness and Internationalisation and Portuguese

Fundação para a Ciência e a Tecnologia

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference179 articles.

1. The journey from discoveries in fundamental immunology to cancer immunotherapy;Miller;Cancer Cell.,2015

2. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma;Keys;N. Engl. J. Med.,1999

3. The Blockade of Immune Checkpoints in Cancer Immunotherapy;Pardoll,2012

4. IL-2: the first effective immunotherapy for human cancer;Rosenberg;J. Immunol.,2014

5. Peptide Vaccine Immunotherapy Biomarkers and Response Patterns in Pediatric Gliomas;Müller,2018

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lentinan-based pH-responsive nanoparticles achieve the combination therapy of tumors;International Journal of Biological Macromolecules;2024-11

2. Immunomodulatory metal-based biomaterials for cancer immunotherapy;Journal of Controlled Release;2024-11

3. Jump-starting chimeric antigen receptor-T cells to go the extra mile with nanotechnology;Current Opinion in Biotechnology;2024-10

4. Synergistic Chemo-Immunotherapy: Recombinant Fusion Protein-Based Surface Modification of NK Cell for Targeted Cancer Treatment;Pharmaceutics;2024-09-08

5. Rational formulation and industrial manufacturing of lipid-based complex injectables: Landmarks and trends;Journal of Controlled Release;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3